iRhythm price target lowered to $125 from $137 at Canaccord

Canaccord lowered the firm’s price target on iRhythm (IRTC) to $125 from $137 and keeps a Buy rating on the shares. The firm said they reported a solid Q3/24 and gave guidance in-line with expectations but they lowered their target to reflect both lower comp group multiples and slightly lower 2025 revenue due to the pushout of ZioMCT.